Cystic Fibrosis in the Era of Precision Medicine: Transformative Progress and Persistent Challenges.

Over the past decade, the therapeutic landscape of cystic fibrosis (CF) has undergone a historic transformation; once considered a progressive, life-limiting multisystem disease treated exclusively with symptomatic therapies, CF has entered the era of mutation-specific treatment, for Contribution 1 [...].